Modular precision multi-payload targeting across solid and liquid tumors
Our lead candidate is an EpCAM-targeted RNA nanoparticle for metastatic colorectal cancer with a validated oncology payload.
About RNA NanoBiotics
About us
RNA NanoBiotics is a biotechnology company developing targeted RNA nanoparticle therapeutics for difficult-to-treat cancers. Our lead program is designed to deliver an approved chemotherapeutic payload specifically to metastatic colorectal cancer cells, reducing systemic toxicity and accelerating clinical entry through a 505(b)(2) strategy. Supported by peer-reviewed science and issued patents, the platform is engineered for adaptability across additional oncology targets following initial clinical validation.
RNA NanoBiotics Team
James J Carroll, MBA
Dr Krystle Karoscik, PhD
Dr Krystle Karoscik, PhD
President, CEO and Chairman
25+ years in Executive Management, strategy, corporate and business development, and investments. President of Wharton Alumni Angels
Wharton
Dr Krystle Karoscik, PhD
Dr Krystle Karoscik, PhD
Dr Krystle Karoscik, PhD
Chief Technology Officer
Technology, Operations and Strategy Executive, Niche in Translational Research and Clinical & Commercial Strategy, Serial entrepreneur in therapeutics and med-tech, Led >20 early-stage clinical programs, Managing Director of Life Sciences, Wharton Alumni Angels, VP BoD Penn Club of Boston; Co-Chair of Women in Lead
Chief Technology Officer
Technology, Operations and Strategy Executive, Niche in Translational Research and Clinical & Commercial Strategy, Serial entrepreneur in therapeutics and med-tech, Led >20 early-stage clinical programs, Managing Director of Life Sciences, Wharton Alumni Angels, VP BoD Penn Club of Boston; Co-Chair of Women in Leadership fostering development in STEM and finance
Penn
Dr. Peixuan Guo
Dr Krystle Karoscik, PhD
Dr Ildiko Csiki, MD. PhD
Chairman Scientific Advisory Board
Professor, Sylvan G. Frank Endowed Chair
Pharmaceutics and Pharmacology, Ohio State University; 2021 Innovator Of The Year Ohio State University; Fellow of the National Academy of Inventors (NAI); Director of Center for RNA Nanobiotechnology and Nanomedicine; President of International Society of RNA Nanot
Chairman Scientific Advisory Board
Professor, Sylvan G. Frank Endowed Chair
Pharmaceutics and Pharmacology, Ohio State University; 2021 Innovator Of The Year Ohio State University; Fellow of the National Academy of Inventors (NAI); Director of Center for RNA Nanobiotechnology and Nanomedicine; President of International Society of RNA Nanotechnology and Nanomedicine; International Society of RNA Nanotechnology and Nanomedicine
Dr Ildiko Csiki, MD. PhD
Dr Ildiko Csiki, MD. PhD
Dr Ildiko Csiki, MD. PhD
Board Member
Pioneered strategic initiatives in drug development, leading to significant advancements in cancer treatment and patient care. Spearheaded the development and commercialization of groundbreaking therapies, overseeing research, business development, and licensing. Expert in clinical trial design.
Wharton
Dr Cynthia Cai, PhD, MBA
Dr Ildiko Csiki, MD. PhD
Dr Cynthia Cai, PhD, MBA
Board Member
Executive & Investor with 25+ years in healthcare and life sciences, experienced in equity investment, board governance, marketing, and business development; Board Member of Spectral AI (NASDAQ: MDAI), Arthrosi Therapeutics, Amberstone Biosciences, Basking Biosciences, HAYA Therapeutics, and the Science History Institute.
Wharton.